Name: Global Vaccines Administered Orally Market Insights and Forecast to 2035
Brand: Extent Research
Price: 3500 USD
Availability: InStock
Rating: 4.6 (255 reviews)

Global Vaccines Administered Orally Market

Market Size in USD Billion

CAGR : 17.60%

USD 1.14

2025

USD 4.17

2033

Forecast Period	2025 - 2033
Market Size (Base Year)	USD 1.14 Billion
Market Size (Forecast)	USD 4.17 Billion
CAGR	17.60%
Major Market Players	Data provided in full report

The latest research report on global Vaccines Administered Orally market was conducted across variety of competitive players in various regions in order to provide realistic and foolproof data. The report offers all the quantifiable and qualitative data based on vital aspects including market opportunities, challenges, risks, competitors, regional players, and latest development trends. In the report, the top players in market, Merck, GSK, Sanofi, Lanzhou Institute, Serum Institute, Valneva, Shanghai United Cell, Bibcol, PaxVax, Vabiotech, Tiantan Biological, EuBiologics, Panacea Biotec Ltd, Bio-Med, Halfkin Bio-Pharmaceuticals, are profiled. Another important point is that the report contains the import/export policies, market share & revenue, and business strategies details that tend to have a huge impact on the global Vaccines Administered Orally market. Furthermore, the other relevant and valuable factors provided by the report include finances, product portfolio, investment planning, and marketing & business strategy.

Data provided by Extent Research. Source: https://www.extentresearch.com/vaccines-administered-orally-market

The graphs and tables in the report help better understand the numerical and theoretical data associated with the market growth during the forecast period. Additionally, the regions North America, Europe, Asia Pacific, Latin America, Middle East & Africa, show the Vaccines Administered Orally market to flourish and gain momentum during forecast period. The Vaccines Administered Orally market is expected to boom in the regions basically due to the various government policies, high supply & demand, business tactics, and various technological developments. In the end, the report speaks more vibrantly about the market growth rate, growth drivers, and statistical increment during the foreseeable timeframe.

Segmentation of the Global Vaccines Administered Orally Market:

By Product type

Human, Animal,

by Application

Public, Private,

Quantifiable data:

Breakdown data depending on diverse segmentation (Key players, Regions, Applications, & Others)
Market sales and growth rate (Historical, current, & forecast)
Market size, share, and revenue
Market pricing and supply & demand chain

Qualitative data:

Market overview
Vaccines Administered Orally market growth influencers
Global Vaccines Administered Orally market trends
Business policies and government regulations
Vaccines Administered Orally market opportunities, challenges, and threats
Market entropy

Questions answered by the report:

What are the factors influencing the global Vaccines Administered Orally market growth/
What is the expected growth rate of the Vaccines Administered Orally market during the forecast period?
Which are the regions experiencing a boom in Vaccines Administered Orally market?
What is expected market size and share during the forecast period?

Report Scope and Market Segmentation

ATTRIBUTES	Global Vaccines Administered Orally Market KEY MARKET INSIGHTS
Segments Covered	By Product Type: All Products Type Includes By Application: All Application Type Includes By End User: All End User Type Includes By Distribution Channel: All Distribution Channel Includes
Countries Covered	North America U.S., Canada, Mexico Europe Germany, United Kingdom, France, Italy, Spain, Nordic Countries, Benelux Union, Rest of Europe Asia-Pacific China, India, Japan, New Zealand, South Korea, Australia, Southeast Asia, Rest of Asia Pacific Latin America Brazil, Argentina, Rest of Latin America Middle East & Africa Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa
Key Market Players	Leading Tier 1 Corporations Prominent Regional Manufacturers Emerging Market Disruptors Technology Integrators & Suppliers *Complete vendor layout of 15+ major players provided in the final report.
Market Opportunities	Market Size and Growth: Quantifying the total addressable market (TAM) and projected growth rates to assess financial viability. Customer Segmentation: Identifying target audience behaviors, pain points, and specific unfulfilled demands. Competitive Landscape: Analyzing existing competitors' strengths, weaknesses, and market share to pinpoint gaps and opportunities. Industry Trends: Mapping technological, regulatory, and economic shifts that create favorable conditions for market entry. Risk Assessment: Evaluating barriers to entry and operational challenges alongside strategic roadmaps for mitigation.
Value Added Data Infosets	In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by our expert team also include in-depth expert analysis, geographically represented company-wise production and capacity, network layouts of distributors and partners, detailed and updated price trend analysis and deficit analysis of supply chain and demand.

Meet the Team

Julie

Author

Julie Jayne is a distinguished multidisciplinary strategist and the Head of Research at Extent Research, where she leverages over a decade of comprehensive experience in the global market intelligence industry. Backed by a robust academic foundation that includes a B.Sc. and an MBA, she perfectly...

Priya M

Reviewed By

With over 14 years of dedicated professional expertise in business-to-business (B2B) intelligence, Priya M stands as a distinguished leader in corporate strategy, revenue growth, and advanced data analysis. Her dynamic career is defined by a relentless focus on mitigating business risks and empowering corporate executives...

Learn more about Priya M

BASIC ATTRIBUTES \| KEY MARKET INSIGHTS
Report Title	Global Vaccines Administered Orally Market
Base Year	2025
Forecast Period	2025 - 2033
Market Size (Base)	USD 1.14 Billion
Projected Size	USD 4.17 Billion
CAGR	17.60%

                            1 Study Coverage
    1.1 Vaccines Administered Orally Product Introduction
    1.2 Market by Type
        1.2.1 Global Vaccines Administered Orally Market Size Growth Rate by Type, 2017 VS 2021 VS 2035
        1.2.2 Human
        1.2.3 Animal
    1.3 Market by Application
        1.3.1 Global Vaccines Administered Orally Market Size Growth Rate by Application, 2017 VS 2021 VS 2035
        1.3.2 Public
        1.3.3 Private
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Vaccines Administered Orally Sales Estimates and Forecasts 2017-2035
    2.2 Global Vaccines Administered Orally Revenue Estimates and Forecasts 2017-2035
    2.3 Global Vaccines Administered Orally Revenue by Region: 2017 VS 2021 VS 2035
    2.4 Global Vaccines Administered Orally Sales by Region
        2.4.1 Global Vaccines Administered Orally Sales by Region (2017-2022)
        2.4.2 Global Sales Vaccines Administered Orally by Region (2023-2035)
    2.5 Global Vaccines Administered Orally Revenue by Region
        2.5.1 Global Vaccines Administered Orally Revenue by Region (2017-2022)
        2.5.2 Global Vaccines Administered Orally Revenue by Region (2023-2035)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Vaccines Administered Orally Sales by Manufacturers
        3.1.1 Global Top Vaccines Administered Orally Manufacturers by Sales (2017-2022)
        3.1.2 Global Vaccines Administered Orally Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Vaccines Administered Orally in 2021
    3.2 Global Vaccines Administered Orally Revenue by Manufacturers
        3.2.1 Global Vaccines Administered Orally Revenue by Manufacturers (2017-2022)
        3.2.2 Global Vaccines Administered Orally Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Vaccines Administered Orally Revenue in 2021
    3.3 Global Vaccines Administered Orally Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Vaccines Administered Orally Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Vaccines Administered Orally Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Vaccines Administered Orally Sales by Type
        4.1.1 Global Vaccines Administered Orally Historical Sales by Type (2017-2022)
        4.1.2 Global Vaccines Administered Orally Forecasted Sales by Type (2023-2035)
        4.1.3 Global Vaccines Administered Orally Sales Market Share by Type (2017-2035)
    4.2 Global Vaccines Administered Orally Revenue by Type
        4.2.1 Global Vaccines Administered Orally Historical Revenue by Type (2017-2022)
        4.2.2 Global Vaccines Administered Orally Forecasted Revenue by Type (2023-2035)
        4.2.3 Global Vaccines Administered Orally Revenue Market Share by Type (2017-2035)
    4.3 Global Vaccines Administered Orally Price by Type
        4.3.1 Global Vaccines Administered Orally Price by Type (2017-2022)
        4.3.2 Global Vaccines Administered Orally Price Forecast by Type (2023-2035)
5 Market Size by Application
    5.1 Global Vaccines Administered Orally Sales by Application
        5.1.1 Global Vaccines Administered Orally Historical Sales by Application (2017-2022)
        5.1.2 Global Vaccines Administered Orally Forecasted Sales by Application (2023-2035)
        5.1.3 Global Vaccines Administered Orally Sales Market Share by Application (2017-2035)
    5.2 Global Vaccines Administered Orally Revenue by Application
        5.2.1 Global Vaccines Administered Orally Historical Revenue by Application (2017-2022)
        5.2.2 Global Vaccines Administered Orally Forecasted Revenue by Application (2023-2035)
        5.2.3 Global Vaccines Administered Orally Revenue Market Share by Application (2017-2035)
    5.3 Global Vaccines Administered Orally Price by Application
        5.3.1 Global Vaccines Administered Orally Price by Application (2017-2022)
        5.3.2 Global Vaccines Administered Orally Price Forecast by Application (2023-2035)
6 North America
    6.1 North America Vaccines Administered Orally Market Size by Type
        6.1.1 North America Vaccines Administered Orally Sales by Type (2017-2035)
        6.1.2 North America Vaccines Administered Orally Revenue by Type (2017-2035)
    6.2 North America Vaccines Administered Orally Market Size by Application
        6.2.1 North America Vaccines Administered Orally Sales by Application (2017-2035)
        6.2.2 North America Vaccines Administered Orally Revenue by Application (2017-2035)
    6.3 North America Vaccines Administered Orally Market Size by Country
        6.3.1 North America Vaccines Administered Orally Sales by Country (2017-2035)
        6.3.2 North America Vaccines Administered Orally Revenue by Country (2017-2035)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Vaccines Administered Orally Market Size by Type
        7.1.1 Europe Vaccines Administered Orally Sales by Type (2017-2035)
        7.1.2 Europe Vaccines Administered Orally Revenue by Type (2017-2035)
    7.2 Europe Vaccines Administered Orally Market Size by Application
        7.2.1 Europe Vaccines Administered Orally Sales by Application (2017-2035)
        7.2.2 Europe Vaccines Administered Orally Revenue by Application (2017-2035)
    7.3 Europe Vaccines Administered Orally Market Size by Country
        7.3.1 Europe Vaccines Administered Orally Sales by Country (2017-2035)
        7.3.2 Europe Vaccines Administered Orally Revenue by Country (2017-2035)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Vaccines Administered Orally Market Size by Type
        8.1.1 Asia Pacific Vaccines Administered Orally Sales by Type (2017-2035)
        8.1.2 Asia Pacific Vaccines Administered Orally Revenue by Type (2017-2035)
    8.2 Asia Pacific Vaccines Administered Orally Market Size by Application
        8.2.1 Asia Pacific Vaccines Administered Orally Sales by Application (2017-2035)
        8.2.2 Asia Pacific Vaccines Administered Orally Revenue by Application (2017-2035)
    8.3 Asia Pacific Vaccines Administered Orally Market Size by Region
        8.3.1 Asia Pacific Vaccines Administered Orally Sales by Region (2017-2035)
        8.3.2 Asia Pacific Vaccines Administered Orally Revenue by Region (2017-2035)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Vaccines Administered Orally Market Size by Type
        9.1.1 Latin America Vaccines Administered Orally Sales by Type (2017-2035)
        9.1.2 Latin America Vaccines Administered Orally Revenue by Type (2017-2035)
    9.2 Latin America Vaccines Administered Orally Market Size by Application
        9.2.1 Latin America Vaccines Administered Orally Sales by Application (2017-2035)
        9.2.2 Latin America Vaccines Administered Orally Revenue by Application (2017-2035)
    9.3 Latin America Vaccines Administered Orally Market Size by Country
        9.3.1 Latin America Vaccines Administered Orally Sales by Country (2017-2035)
        9.3.2 Latin America Vaccines Administered Orally Revenue by Country (2017-2035)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Vaccines Administered Orally Market Size by Type
        10.1.1 Middle East and Africa Vaccines Administered Orally Sales by Type (2017-2035)
        10.1.2 Middle East and Africa Vaccines Administered Orally Revenue by Type (2017-2035)
    10.2 Middle East and Africa Vaccines Administered Orally Market Size by Application
        10.2.1 Middle East and Africa Vaccines Administered Orally Sales by Application (2017-2035)
        10.2.2 Middle East and Africa Vaccines Administered Orally Revenue by Application (2017-2035)
    10.3 Middle East and Africa Vaccines Administered Orally Market Size by Country
        10.3.1 Middle East and Africa Vaccines Administered Orally Sales by Country (2017-2035)
        10.3.2 Middle East and Africa Vaccines Administered Orally Revenue by Country (2017-2035)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Merck
        11.1.1 Merck Corporation Information
        11.1.2 Merck Overview
        11.1.3 Merck Vaccines Administered Orally Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Merck Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Merck Recent Developments
    11.2 GSK
        11.2.1 GSK Corporation Information
        11.2.2 GSK Overview
        11.2.3 GSK Vaccines Administered Orally Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 GSK Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 GSK Recent Developments
    11.3 Sanofi
        11.3.1 Sanofi Corporation Information
        11.3.2 Sanofi Overview
        11.3.3 Sanofi Vaccines Administered Orally Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Sanofi Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Sanofi Recent Developments
    11.4 Lanzhou Institute
        11.4.1 Lanzhou Institute Corporation Information
        11.4.2 Lanzhou Institute Overview
        11.4.3 Lanzhou Institute Vaccines Administered Orally Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Lanzhou Institute Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Lanzhou Institute Recent Developments
    11.5 Serum Institute
        11.5.1 Serum Institute Corporation Information
        11.5.2 Serum Institute Overview
        11.5.3 Serum Institute Vaccines Administered Orally Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Serum Institute Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Serum Institute Recent Developments
    11.6 Valneva
        11.6.1 Valneva Corporation Information
        11.6.2 Valneva Overview
        11.6.3 Valneva Vaccines Administered Orally Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Valneva Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Valneva Recent Developments
    11.7 Shanghai United Cell
        11.7.1 Shanghai United Cell Corporation Information
        11.7.2 Shanghai United Cell Overview
        11.7.3 Shanghai United Cell Vaccines Administered Orally Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Shanghai United Cell Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Shanghai United Cell Recent Developments
    11.8 Bibcol
        11.8.1 Bibcol Corporation Information
        11.8.2 Bibcol Overview
        11.8.3 Bibcol Vaccines Administered Orally Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Bibcol Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Bibcol Recent Developments
    11.9 PaxVax
        11.9.1 PaxVax Corporation Information
        11.9.2 PaxVax Overview
        11.9.3 PaxVax Vaccines Administered Orally Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 PaxVax Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 PaxVax Recent Developments
    11.10 Vabiotech
        11.10.1 Vabiotech Corporation Information
        11.10.2 Vabiotech Overview
        11.10.3 Vabiotech Vaccines Administered Orally Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 Vabiotech Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Vabiotech Recent Developments
    11.11 Tiantan Biological
        11.11.1 Tiantan Biological Corporation Information
        11.11.2 Tiantan Biological Overview
        11.11.3 Tiantan Biological Vaccines Administered Orally Sales, Price, Revenue and Gross Margin (2017-2022)
        11.11.4 Tiantan Biological Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
        11.11.5 Tiantan Biological Recent Developments
    11.12 EuBiologics
        11.12.1 EuBiologics Corporation Information
        11.12.2 EuBiologics Overview
        11.12.3 EuBiologics Vaccines Administered Orally Sales, Price, Revenue and Gross Margin (2017-2022)
        11.12.4 EuBiologics Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
        11.12.5 EuBiologics Recent Developments
    11.13 Panacea Biotec Ltd
        11.13.1 Panacea Biotec Ltd Corporation Information
        11.13.2 Panacea Biotec Ltd Overview
        11.13.3 Panacea Biotec Ltd Vaccines Administered Orally Sales, Price, Revenue and Gross Margin (2017-2022)
        11.13.4 Panacea Biotec Ltd Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
        11.13.5 Panacea Biotec Ltd Recent Developments
    11.14 Bio-Med
        11.14.1 Bio-Med Corporation Information
        11.14.2 Bio-Med Overview
        11.14.3 Bio-Med Vaccines Administered Orally Sales, Price, Revenue and Gross Margin (2017-2022)
        11.14.4 Bio-Med Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
        11.14.5 Bio-Med Recent Developments
    11.15 Halfkin Bio-Pharmaceuticals
        11.15.1 Halfkin Bio-Pharmaceuticals Corporation Information
        11.15.2 Halfkin Bio-Pharmaceuticals Overview
        11.15.3 Halfkin Bio-Pharmaceuticals Vaccines Administered Orally Sales, Price, Revenue and Gross Margin (2017-2022)
        11.15.4 Halfkin Bio-Pharmaceuticals Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
        11.15.5 Halfkin Bio-Pharmaceuticals Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Vaccines Administered Orally Industry Chain Analysis
    12.2 Vaccines Administered Orally Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Vaccines Administered Orally Production Mode & Process
    12.4 Vaccines Administered Orally Sales and Marketing
        12.4.1 Vaccines Administered Orally Sales Channels
        12.4.2 Vaccines Administered Orally Distributors
    12.5 Vaccines Administered Orally Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Vaccines Administered Orally Industry Trends
    13.2 Vaccines Administered Orally Market Drivers
    13.3 Vaccines Administered Orally Market Challenges
    13.4 Vaccines Administered Orally Market Restraints
14 Key Findings in The Global Vaccines Administered Orally Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer                        

Research Methodology

Data collection and base year analysis are done using proprietary data collection modules with large sample sizes. The process includes obtaining market information through extensive secondary sources, paid databases, and verifying data via primary (industry expert) validation.

Our market models include Vendor Positioning Grids, Market Timeline Analysis, Company Market Share Analysis, and Top-Down/Bottom-Up forecasting models. To know more about the research methodology, drop an inquiry to speak to our industry experts.

Speak to Analyst

Global Vaccines Administered Orally Market